Introduction
============

Recent investigations of cultured extreme environmental microbes revealed numerous bioactive natural products.^[@bib1],[@bib2]^ Diverse secondary metabolites have been isolated from various cultured extreme-tolerant microbes, extremophiles and deep-sea microbes, which exhibited interesting biological activities, such as antitumor, antifungal and antibacterial activity.^[@bib3],\ [@bib4],\ [@bib5],\ [@bib6]^

In the course of our ongoing studies of special environmental microorganisms as sources of new bioactive secondary metabolites, a halotolerant fungus *Myrothecium* sp. GS-17 was isolated from the soil sample of a salina at Gansu province in China. In the preliminary screening of the extracts from liquid fermentation cultures for *in vitro* activity, the fungal GS-17 was found to produce metabolites with strong growth inhibition activity against human leukemia (HL-60) cell line. Chemical investigation of the extract led to the isolation of two new amide derivatives, *N*-acetyl-2,4,10,17-tetrahydroxy-heptadecylamine (**1**) and *N*-acetyl-3,5,11,18-tetrahydroxyoctadecyl-2-amine (**2**). By means of spectroscopic analysis (UV, IR, NMR and MS) and physico-chemical properties, their chemical structures were determined respectively. Herein, we describe the isolation, structure elucidation and biological activities of the two compounds.

Results
=======

The extract of fermented broth of *Myrothecium* sp. GS-17 was fractionated by repeated column chromatography to yield compounds **1** and **2** ([Figure 1](#fig1){ref-type="fig"}). Their structures were elucidated on the basis of spectroscopic methods.

Physicochemical properties
--------------------------

### N-acetyl-2,4,10,17-tetrahydroxyheptadecylamine (1)

White amorphous powder; mp 143 °C, \[α\]~[D]{.smallcaps}~^20^=−11.5 (*c* 0.13, MeOH); UV (MeOH) *λ*~max~ (log *ɛ*) 209 nm (1.67); IR (KBr) *ν*~max~ 3290, 2922, 2849, 1623 cm^−1^; ESI-MS *m/z* 384.3 \[M+Na\]^+^, HRESI-MS *m/z* 384.2730 \[M+Na\]^+^ (calcd. for C~19~H~39~NaNO~5~^+^, 384.2720); EI-MS *m/z* 228, 146, 128, 102, 73, 43. ^1^H-NMR (300 MHz, pyridine-*d*~5~) and ^13^C-NMR (150 MHz, pyridine-*d*~5~) data are shown in [Table 1](#tbl1){ref-type="table"}.

### N-acetyl-3,5,11,18-tetrahydroxyoctadecyl-2-amine (2)

White amorphous powder; mp 142 °C, \[α\]~[D]{.smallcaps}~^20^=−40 (*c* 0.13, MeOH); UV (MeOH) *λ*~max~ (log *ɛ*) 207 nm (1.56); IR (KBr) *ν*~max~ 3331, 2924, 2850, 1619 cm^−1^; ESI-MS *m/z* 376.1 \[M+H\]^+^, HRESI-MS *m/z* 398.2886 \[M+Na\]^+^ (calcd. for C~20~H~41~NaNO~5~^+^, 398.2877); EI-MS *m/z* 242, 160, 142, 116, 87, 43. ^1^H-NMR (300 MHz, pyridine-*d*~5~) and ^13^C-NMR (150 MHz, pyridine-*d*~5~) data are shown in [Table 1](#tbl1){ref-type="table"}.

Structure determination
-----------------------

Compound **1** was isolated as an amorphous powder, and its molecular formula was determined as C~19~H~39~NO~5~ by HRESI-MS (*m*/*z* 384.2730 \[M+Na\]^+^, calcd. 384.2720), with one degree of unsaturation ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). The ^1^H-NMR (300 MHz, pyridine-*d*~5~) spectrum ([Table 1](#tbl1){ref-type="table"},[Supplementary Figure S5](#sup1){ref-type="supplementary-material"}) of **1** displayed signals for one amide proton at *δ*~H~ 8.68 (1H, t, *J*=5.6 Hz), four hydroxyl protons at *δ*~H~ 6.40 (1H, br s), 5.95 (1H, br s), 5.87 (1H, br s) and 5.59 (1H, br s), three oxymethines at *δ*~H~ 4.66 (1H, m), 4.38 (1H, br s) and 3.81 (1H, m). Inspection of ^13^C-NMR and the DEPT spectra ([Table 1](#tbl1){ref-type="table"},[Supplementary Figures S6 and S7](#sup1){ref-type="supplementary-material"}) revealed the existence of 19 carbons including one carbonyl carbon at *δ*~C~ 170.5, three oxymethines at *δ*~C~ 70.9, 68.4, 68.1, one oxymethylene *δ*~C~ 62.1, one nitrogen-bearing sp^3^ methylene at *δ*~C~ 47.2 and one methyl group at *δ*~C~ 23.1. Six aliphatic methylene signals \[*δ*H 1.37--1.78 (12H, m), *δ*~C~ 26.3--30.4\] suggested the presence of aliphatic chain. The proton and carbon signals ([Table 1](#tbl1){ref-type="table"}) were assigned from the 2D-NMR (^1^H-^1^H COSY, HSQC and HMBC).

The ^1^H-^1^H COSY spectra ([Figure 2](#fig2){ref-type="fig"} and [Supplementary Figure S8](#sup1){ref-type="supplementary-material"}) of **1** disclosed two structural units of NH-C1-C2-C3-C4-C5, C2-OH, C4-OH and C16-C17-OH, suggesting the presence of 2,4,17-trihydroxy groups. In the HMBC spectrum ([Figure 2](#fig2){ref-type="fig"} and [Supplementary Figure S10](#sup1){ref-type="supplementary-material"}), the correlations from N-H (*δ*~H~ 8.68) and methyl protons H-2\' (*δ*~H~ 2.07) to a carbonyl carbon C-1\' (*δ*~C~ 170.5), and from N-H (*δ*~H~ 8.68) to C-1 (*δ*~C~ 47.2) indicated that C-1 was substituted by an acetylamino group.

The position of the fourth hydroxyl group was determined to be located at C-10 by a significant fragment ion peak at *m*/*z* 228 \[M−C~7~H~14~OH−H~2~O\]^+^ in EI-MS ([Figure 3](#fig3){ref-type="fig"} and [Supplementary Figure S11](#sup1){ref-type="supplementary-material"}). Thus, the structure of **1** was determined to be *N*-acetyl-2,4,10,17-tetrahydroxyheptadecylamine.^[@bib7]^

Compound **2** was isolated as an amorphous powder, and its molecular formula was determined as C~20~H~41~NO~5~ by HRESI-MS (*m*/*z* 398.2886 \[M+Na\]^+^, calcd. 398.2877), with one degree of unsaturation ([Supplementary Figure S13](#sup1){ref-type="supplementary-material"}). Compared with the NMR data of compound **1**, the ^1^H-, ^13^C-NMR and DEPT data ([Supplementary Figures S16--S18](#sup1){ref-type="supplementary-material"}) indicated **2** was an analog of compound **1**. Inspection of ^13^C-NMR ([Table 1](#tbl1){ref-type="table"}) and the DEPT spectra of **2** revealed that compound **2** possessed one more methyl than compound **1**. The nitrogen-bearing methylene at *δ*~C~ 47.2 of compound **1** was replaced by a nitrogen-bearing methine at *δ*~C~ 50.4. The HMBC correlations ([Figure 2](#fig2){ref-type="fig"} and [Supplementary Figure S21](#sup1){ref-type="supplementary-material"}) from H-1 to C-2 and C-3 suggested an acetylamino at C-2. 11-Hydroxy group location was determined by a fragment ion peak at *m*/*z* 242 \[M−C~7~H~14~OH−H~2~O\]^+^ in EI-MS ([Figure 3](#fig3){ref-type="fig"} and [Supplementary Figure S22](#sup1){ref-type="supplementary-material"}). Thus, the structure of **2** was determined to be *N*-acetyl-3,5,11,18-tetrahydroxyoctadecyl-2-amine.^[@bib7]^

Biological activity
-------------------

The cancer cell cytotoxicities of compounds **1** and **2** were evaluated. The cytotoxic potential of the isolated compounds was investigated by determining their concentrations required for 50% growth inhibition (IG~50~ value) for three human cancer cell lines (HL-60, MCF-7, PC-3). Compound **2** shows a weak activity against human leukemia (HL-60) cancer cell with IG~50~ value of 63.61 μ[M]{.smallcaps}.

Discussion
==========

Our investigation on the metabolites of the halotolerant fungus *Myrothecium* sp. GS-17 has resulted in the isolation of two new amides, *N*-acetyl-2,4,10,17-tetrahydroxyheptadecylamine (**1**) and *N*-acetyl-3,5,11,18-tetrahydroxyoctadecyl-2-amine (**2**). Compound **2** shows a weak activity against HL-60 cancer cells. The notable growth inhibition activity of the original extract against HL-60 cell line could be attributed to the presence of trichothecenes, which was reported to show various remarkable cytotoxic activities.^[@bib8]^ Compound **2** has one more methyl than **1**, which increased the cytotoxic activity against human leukemia (HL-60) cancer cell in this kind of amide structure. These two compounds belong to ceramide (or sphingolipid) analogs, which are a family of important lipid in skin, hair and nail of human and animal\'s brain.^[@bib9],[@bib10]^ In addition, people found that ceramides have relatively potent antitumor activity.^[@bib11]^

Methods
=======

General experimental procedures
-------------------------------

The UV spectra were conducted on a UV-2201 spectrometer (Shimadzu, Kyoto, Japan). The FT-IR spectra were obtained on a Bruker IFS-55 spectrometer (Bruker, Ettlingen, Germany) by a KBr disk method. ESI-MS spectra were conducted on an Agilent 1100 ion trap spectrometer (Agilent Technologies, Palo Alto, CA, USA). HRESI-MS was recorded on a QFT-ESI mass spectrometer (Varian, Palo Alto, CA, USA). ^1^H-NMR and ^13^C-NMR spectra were recorded on Bruker ARX-300 and AV-600 NMR spectrometers (Bruker, Ettlingen, Germany) using pyridine-*d*~5~ as an internal standard \[*δ*~H/C~ 7.20, 7.57, 8.72/123.44, 135.43, 149.84 (C~5~D~5~N)\]. Optical rotations were measured with a Perkin-Elmer 241 polarimeter (Perkin-Elmer, Boston, MA, USA). The chromatographic silica gel (200−300 mesh) was purchased from Qingdao Ocean Chemical Factory (Qingdao, China) and ODS (50 μm) was purchased from YMC Co. Ltd, Kyoto, Japan. Sephadex LH-20 was purchased from GE Healthcare, Uppsala, Sweden. RP-HPLC analysis and semi-preparation were conducted using HITACHI L2130 series pumping system equipped with a HITACHI L2400 UV detector (Tokyo, Japan) and performed with a C-18 column (10 × 250 mm, 10 μm; YMC Co. Ltd, Kyoto, Japan).

Strain
------

The halotolerant fungal strain GS-17 was separated by dilution isolation method from the soil sample of a salina at Gansu province. The fungus was identified as *Myrothecium* sp. on the basis of morphological and blast search of ITS sequence using the Genbank database. The morphology of the strain GS-17 displays that the colonies are white, ball and flocculent with black oil secretions on the surface. The sizes of strains are 0.5--2.5 μm × 6--10 μm, and they are round and opaque with irregular edge and surface projection. In addition, colonies are beige granules in liquid nutrient medium. ITS sequence of strain GS-17 showed 100% homology with those of *Myrothecium verrucaria* (GenBank accession number HQ625520) and *Myrothecium atroviride* (GenBank accession number AJ302002; [Supplementary Figure S23](#sup1){ref-type="supplementary-material"}). The voucher specimen was deposited in Department of Natural Products Chemistry, Shenyang Pharmaceutical University, China. The initial cultures were maintained on the potato dextrose agar (PDA) plate.

Fermentation
------------

A small loop of spores growing on a PDA slant was inoculated into a 250 ml Erlenmeyer flask containing 75 ml sea-water-based culture medium (maltose 2%, monosodium glutamate 1%, KH~2~PO~4~ 0.05%, MgSO~4~·7H~2~O 0.03%, glucose 1%, yeast extract 0.3%, corn steep liquor 0.1%, mannitol 2%, sea water, pH 6.5) and cultured at 28 °C for 2 days on a rotary shaker at 180 rotations per minute. Then, 10 ml of the resultant seed culture was inoculated into a 500 ml Erlenmeyer flask containing 150 ml of the above culture medium and incubated (500 flasks) for 8 days at the same conditions.

Extraction and isolation
------------------------

The fermented broth (56 l) was filtered through cheese cloth to yield the supernatant and mycelia. The supernatant was subjected to HPD100 macroporous absorption resin, eluted in gradient with EtOH/H~2~O 30%, 70%, 100% to yield three fractions (1--3). Fraction 2 was fractioned on a silica gel column eluting with CH~2~Cl~2~−MeOH (from 100:0 to 0:100) and was further separated by a flash silica gel column (eluted with petroleum ether/acetone, 10:1) to give three subfractions (A--C). Subfraction A was further purified by RP-HPLC \[MeCN/H~2~O (65%), 2.0 ml min^−1^\] to yield **1** (10.0 mg) and **2** (6.0 mg).

*In vitro* cytotoxic assay
--------------------------

The *in vitro* cell growth inhibition activities of crude extracts and the isolated compounds in human promyelocytic leukemia HL-60 cell lines were evaluated by the Trypan blue method. In addition, the cell growth inhibition activities of compounds were assayed by the Trypan blue method using human breast adenocarcinoma MCF-7 cell line, and the MTT method using human prostate cancer PC-3 cell line as previously described.^[@bib12],[@bib13]^ The cell lines obtained from American Type Culture Collection, Rockville, MD, USA were cultured in RPMI-1640 medium (Gibco, New York, NY, USA) supplemented with 100 U ml^−1^ penicillin, 100 μg ml^−1^ streptomycin, 1 mmol glutamine and 10% heat-inactivated fetal bovine serum.
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![The structures of compounds **1** and **2**.](ja2014136f1){#fig1}

![Key ^1^H-^1^H COSY and HMBC correlations of compounds **1** and **2**.](ja2014136f2){#fig2}

![Key fragment ions in EI-MS of compounds **1** and **2**.](ja2014136f3){#fig3}

###### NMR spectroscopic data of compounds **1** and **2** (in pyridine-*d* ~5~)

  *Compound **1***    *Compound **2***                                                                                                                                        
  ------------------ ------------------ ------------------------------- ----------------- ---------------- ---------------------------------- ------------------------------- ---------------
  1                   3.87, m 3.67, m                47.2                C-2, C-3, C-1\'  1                          1.40, d (6.7)                         18.0                  C-2, C-3
  2                       4.66, m                    68.4                 C-1, C-3, C-4   2                             4.60, m                            50.4                       
  3                    1.94, t (6.0)                 43.3                 C-1, C-4, C-5   3                             4.52, m                            71.1                       
  4                      4.38, br s                  68.1                   C-2, C-6      4                 1.99, 2.01, ddd (16.7, 8.9, 3.0)               42.4                C-3, C-5, C-6
  5                   1.76, m 1.64, m                39.1                      C-4        5                             4.37, m                            68.4                       
                                                                                          6                         1.79, m 1.67, m                        39.1                     C-5
  6--8 or 12--14         1.37--1.78      26.3 26.5 26.5 30.0 30.3 30.4                    7--9 or 13--15               1.43--1.81              26.3 26.5 26.5 30.0 30.2 30.4          
  9                       1.60, m                    38.5                                 10                            1.63, m                            38.5                       
  10                      3.81, m                    70.9                                 11                            3.81, m                            70.9                       
  11                      1.60, m                    38.5                                 12                            1.63, m                            38.5                       
  15                    1.52, 2 H, m                 26.5                                 16                            1.55, m                            26.4                       
  16                    1.74, 2 H, m                 33.8                                 17                            1.75, m                            33.8                       
  17                      3.86, m                    62.1                  C-15, C-16     18                            3.86, m                            62.1                 C-16, C-17
  -HN                  8.68, t (5.6)                                       C-1, C-1\'     -HN                        8.19, d (8.8)                                                 C-1\'
  1\'                                                170.5                                1\'                                                              169.7                      
  2\'                     2.07, s                    23.1                     C-1\'       2\'                           2.11, s                            23.3                    C-1\'
  2-OH                   6.40, br s                                                       -OH                          6.37, br s                                                     
  4-OH                   5.95, br s                                                       -OH                           5.90, m                                                       
  10-OH                  5.59, br s                                                       -OH                           5.58, m                                                       
  17-OH                  5.87, br s                                                       -OH                           5.68, m                                                       
